We have studied 40 infants with a postconceptual age of less than 60 weeks undergoing general anaesthesia for herniotomy. Patients were anaesthetized with 1 MAC equivalent values for age and agent and allocated randomly to receive halothane, sevoflurane or thiopental for induction, and halothane, sevoflurane or desflurane for maintenance of anaesthesia. At induction, both time to acceptance of a face mask and loss of eyelash reflex were recorded. Emergence times were noted by a blinded observer. Induction and emergence times were similar between the halothane and sevoflurane groups but were consistently shorter in the desflurane group compared with the halothane or sevoflurane groups. There were no problems at extubation or significant apnoea in any group. Induction of anaesthesia in this population was no quicker with sevoflurane than with halothane and the method used for induction did not influence recovery time. Maintenance of anaesthesia with desflurane resulted in a shorter recovery time in infants in whom anaesthesia was induced with halothane or thiopental. Desflurane maintenance may be particularly beneficial in the neonate. (Br.
Neonates, and especially formerly preterm infants, are susceptible to apnoea and ventilatory depression after general anaesthesia. 1 2 An effect of the residual volatile agent may be responsible. Newer agents, including sevoflurane and desflurane, may have advantages over halothane because of their more rapid recovery characteristics. Sevoflurane has a blood:gas solubility of 0.65 which is intermediate between halothane (2.4) and desflurane (0.45). 3 A lower blood:gas solubility should be associated with a more rapid uptake of the inhalation agent, that is faster induction and more rapid recovery when discontinued. This would suggest that desflurane is a suitable agent for use in paediatric anaesthesia. Unfortunately, its use as an induction agent has been limited by the high incidence of airway irritation during inhalation in paediatric patients. 4 Taylor and Lerman have shown that these complications do not occur at extubation. 5 Sevoflurane provides smooth induction with few side effects and is therefore a suitable agent for use in neonates and infants. 6 We have compared halothane, sevoflurane and desflurane, as they are used clinically, in infants aged less than 60 weeks post-conceptual age (PCA).
Patients and methods
After obtaining Ethics Committee approval and written informed consent from parents, we studied 40 patients undergoing inguinal hernia repair. Patients were allocated randomly, using a computergenerated randomization table from "Trialaid" (Dr G. Hutchison, Dundee) to one of four groups of 10 patients. Group size was calculated using "Trialaid" on the basis of having a 95% chance of detecting a 40% difference in mean recovery time with a significance value of 0.05 (estimated mean difference in recovery time of 8 min, P:0.05, power:95%, n:10). In group 1, patients received inhalation induction with halothane, and maintenance with halothane throughout the procedure; in group 2, anaesthesia was induced with halothane and maintained with desflurane; in group 3, anaesthesia was induced with i.v. thiopental (STP) and maintained with desflurane; and in group 4, anaesthesia was induced with sevoflurane and maintained with sevoflurane. All infants were fasted and unpremedicated.
All patients had standard monitoring, including electrocardiogram, pulse oximeter and non-invasive arterial pressure, and an i.v. cannula was sited before induction. Anaesthesia was induced using 60% nitrous oxide in oxygen, delivered via a Mapelson F circuit. Initially a cupped hand was placed on the infant's face and then replaced by a mask as tolerated. Stepwise increases of either halothane (0.5% increments) or sevoflurane (1% increments) were made every 5-10 breaths. Atropine was administered only for treatment of bradycardia (heart rate 100 beat min
91
). Time to acceptance of a face mask was noted and time to loss of the eyelash reflex was taken as the time to sleep. This was assessed every 10 s. Patients were anaesthetized by one of two senior anaesthetists who were not blinded to the inhalation agent. Fresh gas flow during induction of anaesthesia was [6] [7] [8] The infant was then left undisturbed and ventilation continued with 100% oxygen, maintaining normocapnia until spontaneous respiration commenced. The time to first swallow, limb movement (i.e. flexion of the hip joint or movement of the shoulder joint), spontaneous eye opening and extubation were recorded by one of two observers blinded to the agent used. Before the start of the study, both observers were assessed on similar cases to ensure that the same end-points were recorded. Induction, perioperative and immediate postoperative complications were documented. Breath-holding was defined as cessation of breathing or detection of airflow for 10-15 s, and apnoea was defined as cessation of breathing or detection of airflow for 15 s or 15 s with bradycardia (heart rate 80 beat min
). Coughing, laryngospasm, bronchospasm, excitement and other unanticipated events were recorded. All patients were monitored on the ward using pulse oximetry and chest wall impedance monitoring for 24 h after operation. All charts were reviewed to check for postoperative complications. Patient data, including PCA at birth and at the time of surgery, and weight, were recorded, as was time at 1 MAC.
Statistical analysis was performed using Minitab for Windows version 11.12. Data are reported as mean (SD). Continuous variables were analysed using analysis of variance, with Bonferroni's correction for multiple comparisons. In all cases P:0.05 was considered statistically significant.
Results
The groups were comparable in PCA at surgery (P:0.93), gestational age at birth (P:0.37), weight (P:0.89) and time spent at 1 MAC (P:0.98) (table 1) .
Mean time to acceptance of a face mask was slightly shorter with sevoflurane (67 s) than with halothane (76 s), but this small difference was not statistically significant (P:0.51). Similarly, mean time to loss of eyelash reflex was slightly shorter in the sevoflurane group (P:0.57) (table 2) .
Times from discontinuation of inhalation agent to first swallow, limb movement, eye opening and extubation are shown in table 3. Mean times to limb movement, eye opening ( fig. 1 ) and tracheal extubation were significantly shorter in the two desflurane groups (P:0.01) compared with the halothane and sevoflurane groups.
All patients had i.v. cannulae sited before induction of anaesthesia or on the ward if fasting for longer than 4 h. Only one patient required atropine at induction (a very preterm baby who underwent ventilation at birth and was aged 39 weeks (PCA) at the time of surgery). Four patients had an episode of breath-holding during induction, but all were selflimiting. In two of these infants, anaesthesia was induced with halothane and both were very premature babies born at 31 and 33 weeks gestational age. During recovery there was no clinical difference with regard to complications (table 4). In the halothane group there were two episodes of breathholding, one in a baby with abnormal chest wall movement, and the other in a baby born at 33 weeks with a history of apnoea. There was one episode of breath-holding in the sevoflurane group in a very preterm, low birth weight baby with a history of apnoea. In the desflurane group one baby had an episode of breath-holding, and one baby had two self-limiting apnoeas of 15 s. Both were very premature, low birth weight babies. Two of the babies had complications at induction and recovery. However, as the overall complication rate was low, much larger numbers would be required to show with 95% confidence any significant difference between groups.
Discussion
This study suggests that both halothane and sevoflurane are suitable agents for induction of anaesthesia in neonates and infants. When an overpressure technique is used, both soluble (e.g. halothane) and insoluble (e.g. sevoflurane) drugs provide rapid and similar rates of induction, 8 as confirmed in a recent study. 9 In our study, mean induction times were slightly longer (sevoflurane 1 min 56 s; halothane 2 min 1 s) because of the gradual increase in inspired vapour concentration, but were similar to those of Sarner and colleagues 8 where induction time for sevoflurane (1.6 min) was similar to that for halothane (1.7 min) in a group of older children. The assumption that a MAC multiple of one inhalation agent is equipotent to a similar MAC multiple of another agent may be incorrect. 10 Nitrous oxide decreases the MAC of different volatile agents by varying amounts, having most effect on halothane and least effect on desflurane. 6 11 12 Cardiac output is higher in children and a greater proportion of blood flow is directed to vessel-rich tissues, increasing the concentration of anaesthetic at receptor sites in the brain. 13 The lower solubility of inhalation anaesthetics in blood and tissues of neonates and infants provides an additional explanation for the rapid induction in the halothane group.
14 These factors support our results, showing equally rapid induction in both the halothane and sevoflurane groups.
Respiratory complications occurred in high-risk babies, many of whom had a history of apnoea, in the immediate recovery period. Respiratory complications correlated with patient risk factors and not with the anaesthetic agent. 1 2 We confirmed that airway irritation, which occurs with desflurane at induction, did not cause problems at extubation. 5 Of the 20 patients exposed to desflurane for maintenance of anaesthesia, one exhibited breath-holding and one apnoea after extubation. We studied a high-risk group of patients with 28 of the 40 patients (70%) formerly preterm infants and therefore we might have expected to see more respiratory complications. All patients were monitored in the neonatal surgical ICU for 24 h after operation using both pulse oximetry and chest wall impedance monitors. During that time no child suffered apnoea that required supplementary oxygen or bag and mask ventilation, as assessed by the ward staff. Review of the charts, including nursing notes, revealed absence of any further respiratory complications during this time.
Spinal anaesthesia has been recommended for this patient population because of the increased incidence of apnoea after general anaesthesia 15 but this argument may not hold for the newer, low solubility volatile agents. Our study suggests that recovery from maintenance anaesthesia with desflurane is almost twice as fast as that after halothane or sevoflurane ( fig. 1 ). Recovery times in the two desflurane groups were remarkably similar, suggesting that the method of induction does not influence recovery time but is more dependent on the agent used for maintenance of anaesthesia. Recovery times after halothane and sevoflurane maintenance were similar, which is surprising as maintenance times at 1 MAC were comparable. This could be a result of the confounding effects of nitrous oxide on MAC or of different respiratory depressant effects of the two agents in this patient population. There was no tailoring of MAC levels towards the end of surgery and no external stimulation was allowed to facilitate awakening. The wake-up times shown in table 2 are therefore long. Clinically, time to extubation may be reduced by decreasing vapour concentration towards the end of surgery, thus further decreasing emergence time. For the purposes of this study, all infants had spontaneous eye opening and a regular breathing pattern before extubation. All infants appeared to have clinically effective caudal analgesia, as indicated by the fact that no child required supplementary analgesia for a minimum of 6 h after operation. It is recognized that good regional analgesia may contribute to prolonged awakening. Although desflurane is expensive, requires a special vaporizer and is not suitable for induction because of airway irritant properties, rapid emergence from anaesthesia is possible as a result of its low blood:gas and low tissue:gas solubility. 16 Our results showed that infants receiving desflurane achieved recovery milestones more quickly and were ready for extubation on average 6-10 min before their counterparts receiving other inhalation agents (P:0.01). This has particular clinical significance in the neonate.
In summary, the rate of induction and recovery with halothane was comparable with that of sevoflurane in the neonate and formerly preterm infant. However, emergence from anaesthesia was faster in those patients in whom desflurane was used as the maintenance agent, irrespective of the induction agent administered. The incidence of postoperative respiratory complications was low in this study.
